In cervical cancer, a high expression level of HIF-1α and its downstream target, the tumor-associated cell-surface glycoprotein carbonic anhydrase 9 (CA9), is linked with poor prognosis and therapy resistance [121,122,123]. This evidence concerns the gene CA9 and cervical cancer.